p16 loss rescues functional decline of Brca1-deficient mammary stem cells

References

• Mandal PK, Blanpain C, Rossi DJ. DNA damage response in adult stem cells: Pathways and consequences. Nat Rev Mol Cell Biol 2011; 12:198-202; PMID:21304553; http://dx.doi.org/10.1038/nrm3060
   PubMed Web of Science ®Google Scholar
• Sharpless NE, DePinho RA. How stem cells age and why this makes us grow old. Nat Rev Mol Cell Biol 2007; 8:703-13; PMID:17717515; http://dx.doi.org/10.1038/nrm2241
   PubMed Web of Science ®Google Scholar
• Lombard DB, Chua KF, Mostoslavsky R, Franco S, Gostissa M, Alt FW. DNA repair, genome stability, and aging. Cell 2005; 120:497-512; PMID:15734682; http://dx.doi.org/10.1016/j.cell.2005.01.028
   PubMed Web of Science ®Google Scholar
• Molofsky AV, Slutsky SG, Joseph NM, He S, Pardal R, Krishnamurthy J, Sharpless NE, Morrison SJ. Increasing p16INK4a expression decreases forebrain progenitors and neurogenesis during ageing. Nature 2006; 443:448-52; PMID:16957738; http://dx.doi.org/10.1038/nature05091
   PubMed Web of Science ®Google Scholar
• Krishnamurthy J, Ramsey MR, Ligon KL, Torrice C, Koh A, Bonner-Weir S, Sharpless NE. p16INK4a induces an age-dependent decline in islet regenerative potential. Nature 2006; 443:453-7; PMID:16957737; http://dx.doi.org/10.1038/nature05092
   PubMed Web of Science ®Google Scholar
• Janzen V, Forkert R, Fleming HE, Saito Y, Waring MT, Dombkowski DM, Cheng T, DePinho RA, Sharpless NE, Scadden DT. Stem-cell ageing modified by the cyclin-dependent kinase inhibitor p16INK4a. Nature 2006; 443:421-6; PMID:16957735; http://dx.doi.org/10.1038/nature05159
   PubMed Web of Science ®Google Scholar
• Jackson HW, Waterhouse P, Sinha A, Kislinger T, Berman HK, Khokha R. Expansion of stem cells counteracts age-related mammary regression in compound Timp1/Timp3 null mice. Nat Cell Biol 2015; 17:217-27; PMID:25706237; http://dx.doi.org/10.1038/ncb3118
   PubMedGoogle Scholar
• Sperka T, Wang J, Rudolph KL. DNA damage checkpoints in stem cells, ageing and cancer. Nat Rev Mol Cell Biol 2012; 13:579-90; PMID:22914294; http://dx.doi.org/10.1038/nrm3420
   PubMed Web of Science ®Google Scholar
• Behrens A, van Deursen JM, Rudolph KL, Schumacher B. Impact of genomic damage and ageing on stem cell function. Nat Cell Biol 2014; 16:201-7; PMID:24576896; http://dx.doi.org/10.1038/ncb2928
   PubMed Web of Science ®Google Scholar
• Rossi DJ, Bryder D, Seita J, Nussenzweig A, Hoeijmakers J, Weissman IL. Deficiencies in DNA damage repair limit the function of haematopoietic stem cells with age. Nature 2007; 447:725-9; PMID:17554309; http://dx.doi.org/10.1038/nature05862
   PubMed Web of Science ®Google Scholar
• Beerman I, Seita J, Inlay MA, Weissman IL, Rossi DJ. Quiescent hematopoietic stem cells accumulate DNA damage during aging that is repaired upon entry into cell cycle. Cell Stem Cell 2014; 15:37-50; PMID:24813857; http://dx.doi.org/10.1016/j.stem.2014.04.016
   PubMed Web of Science ®Google Scholar
• Sinha M, Jang YC, Oh J, Khong D, Wu EY, Manohar R, Miller C, Regalado SG, Loffredo FS, Pancoast JR, et al. Restoring systemic GDF11 levels reverses age-related dysfunction in mouse skeletal muscle. Science 2014; 344:649-52; PMID:24797481; http://dx.doi.org/10.1126/science.1251152
   PubMed Web of Science ®Google Scholar
• Blau HM, Cosgrove BD, Ho AT. The central role of muscle stem cells in regenerative failure with aging. Nat Med 2015; 21:854-62; PMID:26248268; http://dx.doi.org/10.1038/nm.3918
   PubMed Web of Science ®Google Scholar
• Cao L, Li W, Kim S, Brodie SG, Deng CX. Senescence, aging, and malignant transformation mediated by p53 in mice lacking the Brca1 full-length isoform. Genes Dev 2003; 17:201-13; PMID:12533509; http://dx.doi.org/10.1101/gad.1050003
   PubMed Web of Science ®Google Scholar
• Cao L, Kim S, Xiao C, Wang RH, Coumoul X, Wang X, Li WM, Xu XL, De Soto JA, Takai H, et al. ATM-Chk2-p53 activation prevents tumorigenesis at an expense of organ homeostasis upon Brca1 deficiency. EMBO J 2006; 25:2167-77; PMID:16675955; http://dx.doi.org/10.1038/sj.emboj.7601115
   PubMed Web of Science ®Google Scholar
• Tu Z, Zhuang X, Yao YG, Zhang R. BRG1 is required for formation of senescence-associated heterochromatin foci induced by oncogenic RAS or BRCA1 loss. Mol Cell Biol 2013; 33:1819-29; PMID:23438604; http://dx.doi.org/10.1128/MCB.01744-12
   PubMedGoogle Scholar
• Sedic M, Skibinski A, Brown N, Gallardo M, Mulligan P, Martinez P, Keller PJ, Glover E, Richardson AL, Cowan J, et al. Haploinsufficiency for BRCA1 leads to cell-type-specific genomic instability and premature senescence. Nat Commun 2015; 6:7505; PMID:26106036; http://dx.doi.org/10.1038/ncomms8505
   PubMed Web of Science ®Google Scholar
• Gorrini C, Baniasadi PS, Harris IS, Silvester J, Inoue S, Snow B, Joshi PA, Wakeham A, Molyneux SD, Martin B, et al. BRCA1 interacts with Nrf2 to regulate antioxidant signaling and cell survival. J Exp Med 2013; 210:1529-44; PMID:23857982; http://dx.doi.org/10.1084/jem.20121337
   PubMed Web of Science ®Google Scholar
• Scott A, Bai F, Chan HL, Liu S, Ma J, Slingerland JM, Robbins DJ, Capobianco AJ, Pei XH. p16INK4a suppresses BRCA1-deficient mammary tumorigenesis. Oncotarget 2016; 7:84496-507; PMID:27811360; http://dx.doi.org/10.18632/oncotarget.13015
   PubMedGoogle Scholar
• Bai F, Smith MD, Chan HL, Pei XH. Germline mutation of Brca1 alters the fate of mammary luminal cells and causes luminal-to-basal mammary tumor transformation. Oncogene 2013; 32:2715-25; PMID:22777348; http://dx.doi.org/10.1038/onc.2012.293
   PubMedGoogle Scholar
• Pei XH, Xiong Y. Biochemical and cellular mechanisms of mammalian CDK inhibitors: A few unresolved issues. Oncogene 2005; 24:2787-95; PMID:15838515; http://dx.doi.org/10.1038/sj.onc.1208611
   PubMed Web of Science ®Google Scholar
• Sherr CJ, McCormick F. The RB and p53 pathways in cancer. Cancer Cell 2002; 2:103-12; PMID:12204530; http://dx.doi.org/10.1016/S1535-6108(02)00102-2
   PubMed Web of Science ®Google Scholar
• Orford KW, Scadden DT. Deconstructing stem cell self-renewal: Genetic insights into cell-cycle regulation. Nat Rev Genet 2008; 9:115-28; PMID:18202695; http://dx.doi.org/10.1038/nrg2269
   PubMed Web of Science ®Google Scholar
• Zindy F, Quelle DE, Roussel MF, Sherr CJ. Expression of the p16INK4a tumor suppressor versus other INK4 family members during mouse development and aging. Oncogene 1997; 15:203-11; PMID:9244355; http://dx.doi.org/10.1038/sj.onc.1201178
   PubMed Web of Science ®Google Scholar
• Brenner AJ, Stampfer MR, Aldaz CM. Increased p16 expression with first senescence arrest in human mammary epithelial cells and extended growth capacity with p16 inactivation. Oncogene 1998; 17:199-205; PMID:9674704; http://dx.doi.org/10.1038/sj.onc.1201919
   PubMed Web of Science ®Google Scholar
• Feijoo P, Terradas M, Soler D, Dominguez D, Tusell L, Genesca A. Breast primary epithelial cells that escape p16-dependent stasis enter a telomere-driven crisis state. Breast Cancer Res 2016; 18:7; PMID:26758019; http://dx.doi.org/10.1186/s13058-015-0667-z
   PubMedGoogle Scholar
• Bai F, Chan HL, Scott A, Smith MD, Fan C, Herschkowitz JI, Perou CM, Livingstone AS, Robbins DJ, Capobianco AJ, et al. BRCA1 suppresses epithelial-to-mesenchymal transition and stem cell dedifferentiation during mammary and tumor development. Cancer Res 2014; 74:6161-72; PMID:25239453; http://dx.doi.org/10.1158/0008-5472.CAN-14-1119
   PubMed Web of Science ®Google Scholar
• Kamb A, Gruis NA, Weaver-Feldhaus J, Liu Q, Harshman K, Tavtigian SV, Stockert E, Day RS, Johnson BE, 3rd, Skolnick MH. A cell cycle regulator potentially involved in genesis of many tumor types. Science 1994; 264:436-40; PMID:8153634; http://dx.doi.org/10.1126/science.8153634
   PubMed Web of Science ®Google Scholar
• Herman JG, Merlo A, Mao L, Lapidus RG, Issa J-PJ, Davidson NE, Sidransky D, Baylin SB. Inactivation of the CDKN2/p16/MTS1 gene is frequently associated with aberrant DNA methylation in all common human cancers. Cancer Res 1995; 55:4525-30; PMID:7553621
   PubMed Web of Science ®Google Scholar
• Koboldt DC, Fulton RS, McLellan MD, Schmidt H, Kalicki-Veizer J, McMichael JF, Fulton LL, Dooling DJ, Ding L, Mardis ER, et al. Comprehensive molecular portraits of human breast tumours. Nature 2012; 490:61-70; PMID:23000897; http://dx.doi.org/10.1038/nature11412
   PubMed Web of Science ®Google Scholar
• Pirone JR, D'Arcy M, Stewart DA, Hines WC, Johnson M, Gould MN, Yaswen P, Jerry DJ, Smith Schneider S, Troester MA. Age-associated gene expression in normal breast tissue mirrors qualitative age-at-incidence patterns for breast cancer. Cancer Epidemiol Biomarkers Prev 2012; 21:1735-44; PMID:22859400; http://dx.doi.org/10.1158/1055-9965.EPI-12-0451
   PubMedGoogle Scholar
• Young LJ, Medina D, DeOme KB, Daniel CW. The influence of host and tissue age on life span and growth rate of serially transplanted mouse mammary gland. Exp Gerontol 1971; 6:49-56; PMID:5572739; http://dx.doi.org/10.1016/0531-5565(71)90048-9
   PubMedGoogle Scholar
• Sharpless NE, Bardeesy N, Lee KH, Carrasco D, Castrillon DH, Aguirre AJ, Wu EA, Horner JW, DePinho RA. Loss of p16Ink4a with retention of p19Arf predisposes mice to tumorigenesis. Nature 2001; 413:86-91; PMID:11544531; http://dx.doi.org/10.1038/35092592
   PubMed Web of Science ®Google Scholar
• Pei XH, Bai F, Smith MD, Usary J, Fan C, Pai SY, Ho IC, Perou CM, Xiong Y. CDK inhibitor p18(INK4c) is a downstream target of GATA3 and restrains mammary luminal progenitor cell proliferation and tumorigenesis. Cancer Cell 2009; 15:389-401; PMID:19411068; http://dx.doi.org/10.1016/j.ccr.2009.03.004
   PubMed Web of Science ®Google Scholar
• Huo Y, Macara IG. The Par3-like polarity protein Par3L is essential for mammary stem cell maintenance. Nat Cell Biol 2014; 16:529-37; PMID:24859006; http://dx.doi.org/10.1038/ncb2969
   PubMedGoogle Scholar